Open tender · Germany · Contract notice
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pimecrolimus, ATC D11AH02 für die Zeit 01.05.2025 - 30.04.2027
DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pimecrolimus, ATC D11AH02 für die Zeit 01.05.2025…”. Bids close on 5 March 2027.
The work
Non-exclusive discount agreement for the active substance Pimecrolimus (ATC D11AH02) for the period 01.05.2025 - 30.04.2027.
- agreement is for the active substance Pimecrolimus, ATC D11AH02
- first effective date is 01.05.2025
- ends automatically with the effective date of an exclusive contract
Key facts
- Contract period
- 01.05.2025 - 30.04.2027
- Evaluation
- This is a non-exclusivity agreement, not a standard procurement with a defined evaluation method.
What it takes to qualify
Worth a closer look
- § 130a Absatz 8 SGB V
- §§ 123 and 124 GWB
- DAK-Gesundheit
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Angebotsschreibenmust be submitted with the offer
- Anerkennung der vertraglichen Maßgabensubmission of the signed contract with name or company stamp
- Anlage 1 zum Vertragto be filled out and submitted
- Anlage 2 zum VertragExcel file to be sent to the specified email